title: A subset of Binet stage A CLL patients with TP53 abnormalities and mutated IGHV genes have stable disease.
authors.forename: O G
authors.initials: OG
authors.lastname: Best
authors.forename: A C
authors.initials: AC
authors.lastname: Gardiner
authors.forename: Z A
authors.initials: ZA
authors.lastname: Davis
authors.forename: I
authors.initials: I
authors.lastname: Tracy
authors.forename: R E
authors.initials: RE
authors.lastname: Ibbotson
authors.forename: A
authors.initials: A
authors.lastname: Majid
authors.forename: M J S
authors.initials: MJ
authors.lastname: Dyer
authors.forename: D G
authors.initials: DG
authors.lastname: Oscier
mesh_terms: D006801:Humans; D007143:Immunoglobulin Heavy Chains / Q000235:genetics*; D007135:Immunoglobulin Variable Region / Q000235:genetics; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis / Q000235:genetics*; D009154:Mutation; D011379:Prognosis; D016159:Tumor Suppressor Protein p53 / Q000235:genetics*
chemical_list: D007143:Immunoglobulin Heavy Chains; D007135:Immunoglobulin Variable Region; D016159:Tumor Suppressor Protein p53